-
1.发明授权Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy 有权氨基茚满衍生物，含有它们的药物组合物及其在治疗中的应用公开(公告)号：US09227930B2
公开(公告)日：2016-01-05
申请号：US14317104
申请日：2014-06-27
发明人： Frauke Pohlki , Udo Lange , Wilhelm Amberg , Michael Ochse , Berthold Behl , Charles W. Hutchins
IPC分类号： A61K31/135 , C07C211/27 , C07C311/14 , C07C311/10 , C07D205/04 , C07D231/18 , C07D403/12 , C07D233/84
CPC分类号： C07C311/14 , C07C311/10 , C07C2601/02 , C07C2602/08 , C07D205/04 , C07D231/18 , C07D233/84 , C07D403/12
摘要： The present invention relates to aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminoindane derivatives, and the use of such aminoindane derivatives for therapeutic purposes. The aminoindane derivatives are GlyT1 inhibitors.
摘要翻译： 本发明涉及式（I）的氨基茚满衍生物或其生理上耐受的盐。 本发明涉及包含这种氨基茚满衍生物的药物组合物以及这种氨基茚满衍生物用于治疗目的的用途。 氨基茚满衍生物是GlyT1抑制剂。
-
2.发明授权公开(公告)号：US09067871B2
公开(公告)日：2015-06-30
申请号：US14031265
申请日：2013-09-19
发明人： Wilhelm Amberg , Michael Ochse , Udo Lange , Andreas Kling , Berthold Behl , Wilfried Hornberger , Mario Mezler , Charles W. Hutchins
IPC分类号： A61K31/16 , C07C215/70 , C07C311/05 , C07C215/64 , C07C217/74 , C07C233/18 , C07C233/19 , C07C233/69 , C07C255/58 , C07C271/24 , C07C307/06 , C07C309/65 , C07C311/07 , C07C311/09 , C07C311/10 , C07C311/14 , C07C311/17 , C07C311/18 , C07C311/20 , C07C311/24 , C07C317/18 , C07C317/28 , C07D205/04 , C07D207/10 , C07D207/12 , C07D207/27 , C07D207/36 , C07D207/48 , C07D213/71 , C07D231/18 , C07D233/84 , C07D249/12 , C07D261/08 , C07D275/02 , C07D295/096 , C07D305/08 , C07D333/34 , C07D403/12 , C07F7/08 , C07D401/12 , C07D409/12
CPC分类号： C07C311/05 , C07C215/64 , C07C217/74 , C07C233/18 , C07C233/19 , C07C233/69 , C07C255/58 , C07C271/24 , C07C307/06 , C07C309/65 , C07C311/07 , C07C311/09 , C07C311/10 , C07C311/13 , C07C311/14 , C07C311/17 , C07C311/18 , C07C311/20 , C07C311/24 , C07C317/18 , C07C317/28 , C07C2601/02 , C07C2601/04 , C07C2602/10 , C07D205/04 , C07D207/09 , C07D207/10 , C07D207/12 , C07D207/27 , C07D207/36 , C07D207/48 , C07D213/71 , C07D231/18 , C07D233/84 , C07D249/12 , C07D261/08 , C07D265/30 , C07D275/02 , C07D295/096 , C07D295/135 , C07D305/08 , C07D333/34 , C07D401/12 , C07D403/12 , C07D409/12 , C07F7/081
摘要： The present invention relates to aminotetraline derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminotetraline derivatives, and the use of such aminotetraline derivatives for therapeutic purposes. The aminotetraline derivatives are GlyT1 inhibitors.
-
3.发明申请PHENALKYLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY 有权PHENALKYLAMINE衍生物，含有它们的药物组合物及其在治疗中的使用公开(公告)号：US20140256701A1
公开(公告)日：2014-09-11
申请号：US14282712
申请日：2014-05-20
发明人： Frauke Pohlki , Udo Lange , Wilhelm Amberg , Michael Ochse , Berthold Behl , Wilfried Hornberger , Mario Mezler , Charles W. Hutchins , Sean Turner
IPC分类号： C07D403/12 , C07D231/18 , C07D401/12 , C07D295/135 , C07C311/05 , C07C311/06 , C07D233/84 , C07C311/10
CPC分类号： C07C311/06 , C07C311/04 , C07C311/05 , C07C311/10 , C07C2601/02 , C07C2601/04 , C07D205/04 , C07D207/08 , C07D207/267 , C07D231/18 , C07D233/42 , C07D233/84 , C07D295/135 , C07D401/12 , C07D403/12
摘要： The present invention relates to phenalkylamine derivatives of the formula (I) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such phenalkylamine derivatives, and the use of such phenalkylamine derivatives for therapeutic purposes. The phenalkylamine derivatives are GlyT1 inhibitors.
摘要翻译： 本发明涉及式（I）的苯烷基胺衍生物或其生理上耐受的盐。 本发明涉及包含这种苯烷基胺衍生物的药物组合物，以及这种苯烷基胺衍生物用于治疗目的的用途。 酚烷基胺衍生物是GlyT1抑制剂。
-
4.发明申请AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY 有权氨基嘌呤衍生物，含有它们的药物组合物及其在治疗中的使用公开(公告)号：US20140031331A1
公开(公告)日：2014-01-30
申请号：US14031265
申请日：2013-09-19
发明人： Wilhelm Amberg , Michael Ochse , Udo Lange , Andreas Kling , Berthold Behl , Wilfried Hornberger , Mario Mezler , Charles W. Hutchins
IPC分类号： C07C311/05 , C07D233/84 , C07D231/18 , C07D213/71 , C07D409/12 , C07D207/12 , C07D275/02 , C07D205/04 , C07D403/12 , C07D401/12 , C07C271/24 , C07D333/34
CPC分类号： C07C311/05 , C07C215/64 , C07C217/74 , C07C233/18 , C07C233/19 , C07C233/69 , C07C255/58 , C07C271/24 , C07C307/06 , C07C309/65 , C07C311/07 , C07C311/09 , C07C311/10 , C07C311/13 , C07C311/14 , C07C311/17 , C07C311/18 , C07C311/20 , C07C311/24 , C07C317/18 , C07C317/28 , C07C2601/02 , C07C2601/04 , C07C2602/10 , C07D205/04 , C07D207/09 , C07D207/10 , C07D207/12 , C07D207/27 , C07D207/36 , C07D207/48 , C07D213/71 , C07D231/18 , C07D233/84 , C07D249/12 , C07D261/08 , C07D265/30 , C07D275/02 , C07D295/096 , C07D295/135 , C07D305/08 , C07D333/34 , C07D401/12 , C07D403/12 , C07D409/12 , C07F7/081
摘要： The present invention relates to aminotetraline derivatives of the formula (I) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such aminotetraline derivatives, and the use of such aminotetraline derivatives for therapeutic purposes. The aminotetraline derivatives are GlyT1 inhibitors.
摘要翻译： 本发明涉及式（I）的氨基四氢化萘衍生物或其生理上耐受的盐。 本发明涉及包含这种氨基四氢化萘衍生物的药物组合物，以及这种氨基四氢化萘衍生物用于治疗目的的用途。 氨基四氢叶酸衍生物是GlyT1抑制剂。
-
5.发明授权Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy 有权苯烷基胺衍生物，含有它们的药物组合物及其在治疗中的用途公开(公告)号：US09238619B2
公开(公告)日：2016-01-19
申请号：US14282712
申请日：2014-05-20
发明人： Frauke Pohlki , Udo Lange , Wilhelm Amberg , Michael Ochse , Berthold Behl , Wilfried Hornberger , Mario Mezler , Charles W. Hutchins , Sean Turner
IPC分类号： A61K31/135 , C07C211/25 , C07C311/06 , C07C311/04 , C07C311/05 , C07C311/10 , C07D205/04 , C07D207/08 , C07D207/267 , C07D231/18 , C07D233/42 , C07D295/135 , C07D401/12 , C07D403/12 , C07D233/84
CPC分类号： C07C311/06 , C07C311/04 , C07C311/05 , C07C311/10 , C07C2601/02 , C07C2601/04 , C07D205/04 , C07D207/08 , C07D207/267 , C07D231/18 , C07D233/42 , C07D233/84 , C07D295/135 , C07D401/12 , C07D403/12
摘要： The present invention relates to phenalkylamine derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such phenalkylamine derivatives, and the use of such phenalkylamine derivatives for therapeutic purposes. The phenalkylamine derivatives are GlyT1 inhibitors.
摘要翻译： 本发明涉及式（I）的苯烷基胺衍生物或其生理上耐受的盐。 本发明涉及包含这种苯烷基胺衍生物的药物组合物，以及这种苯烷基胺衍生物用于治疗目的的用途。 酚烷基胺衍生物是GlyT1抑制剂。
-
6.发明申请AMINOINDANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY 有权氨基丹衍生物，含有它们的药物组合物及其在治疗中的使用公开(公告)号：US20140309206A1
公开(公告)日：2014-10-16
申请号：US14317104
申请日：2014-06-27
发明人： Frauke Pohlki , Udo Lange , Wilhelm Amberg , Michael Ochse , Berthold Behl , Charles W. Hutchins
IPC分类号： C07C311/14 , C07D231/18 , C07D205/04 , C07D403/12 , C07C311/10 , C07D233/84
CPC分类号： C07C311/14 , C07C311/10 , C07C2601/02 , C07C2602/08 , C07D205/04 , C07D231/18 , C07D233/84 , C07D403/12
摘要： The present invention relates to aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such aminoindane derivatives, and the use of such aminoindane derivatives for therapeutic purposes. The aminoindane derivatives are GlyT1 inhibitors.
摘要翻译： 本发明涉及式（I）的氨基茚满衍生物或其生理上耐受的盐。 本发明涉及包含这种氨基茚满衍生物的药物组合物以及这种氨基茚满衍生物用于治疗目的的用途。 氨基茚满衍生物是GlyT1抑制剂。
-
公开(公告)号：US10556907B2
公开(公告)日：2020-02-11
申请号：US15248994
申请日：2016-08-26
发明人： Udo Lange , Michael Ochse , Elizabeth van der Kam , Jeroen van Bergeijk , Sean Turner , Frank Oellien , Patrick Walleser , Wilhelm Amberg , Wilfried Hornberger , Herve Geneste , Mario Mezler , Charles Hutchins
IPC分类号： C07D487/04 , C07D471/04
摘要： The invention relates to heterocyclic compounds as S1P modulators, pharmaceutical compositions comprising such compounds, and uses thereof in the treatment, alleviation or prevention of diseases or disorders mediated by an S1P receptor.
-
8.发明授权公开(公告)号：US09656955B2
公开(公告)日：2017-05-23
申请号：US14216222
申请日：2014-03-17
发明人： Wilhelm Amberg , Frauke Pohlki , Udo Lange , Ying X. Wang , Hongyu H. Zhao , Huan-Qiu Li , Jason T. Brewer , Irini Zanze , Justin Dietrich , Anil Vasudevan , Stevan W. Djuric , Yanbin Lao , Charles W. Hutchins
IPC分类号： A61K31/4025 , A61K31/44 , A61K31/4178 , C07D207/09 , C07D403/12 , C07D401/12 , C07D207/48 , C07D401/14 , C07D403/14 , C07D405/14 , C07D487/10 , C07D417/14 , C07D409/14 , C07D495/04 , C07D471/04 , C07D487/04
CPC分类号： C07D207/48 , A61K31/4025 , A61K31/4178 , A61K31/44 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14
摘要： The present invention relates to pyrrolidine derivatives of the formula (I), or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such pyrrolidine derivatives, and the use of such pyrrolidine derivatives for therapeutic purposes. The pyrrolidine derivatives are GlyT1 inhibitors.
-
9.发明申请PHENALKYLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY 审中-公开PHENALKYLAMINE衍生物，含有它们的药物组合物及其在治疗中的使用公开(公告)号：US20150158842A1
公开(公告)日：2015-06-11
申请号：US14617737
申请日：2015-02-09
发明人： Frauke Pohlki , Udo Lange , Wilhelm Amberg , Michael Ochse , Berthold Behl , Charles W. Hutchins , Wilfried Hornberger , Mario Mezler
IPC分类号： C07D401/12
CPC分类号： C07D401/12 , A61K31/357 , A61K31/472 , A61K31/4725 , A61K31/538 , C07D217/02 , C07D217/08 , C07D217/22 , C07D217/26
摘要： The present invention relates to phenalkylamine derivatives of the formula (I) or (II) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such phenalkylamine derivatives, and the use of such phenalkylamine derivatives for therapeutic purposes. The phenalkylamine derivatives are GlyT1 inhibitors.
摘要翻译： 本发明涉及式（I）或（II）的苯烷基胺衍生物或其生理上耐受的盐。 本发明涉及包含这种苯烷基胺衍生物的药物组合物，以及这种苯烷基胺衍生物用于治疗目的的用途。 酚烷基胺衍生物是GlyT1抑制剂。
-
10.发明申请PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY 有权吡咯烷衍生物，含有它们的药物组合物及其在治疗中的使用公开(公告)号：US20140275087A1
公开(公告)日：2014-09-18
申请号：US14216222
申请日：2014-03-17
发明人： Wilhelm Amberg , Frauke Pohlki , Udo Lange , Ying X. Wang , Hongyu H. Zhao , Huan-Qiu Li , Jason T. Brewer , Irini Zanze , Justin Dietrich , Anil Vasudevan , Stevan W. Djuric , Yanbin Lao , Charles W. Hutchins
IPC分类号： C07D207/48 , C07D403/14 , C07D401/14 , C07D403/12 , C07D401/12
CPC分类号： C07D207/48 , A61K31/4025 , A61K31/4178 , A61K31/44 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14
摘要： The present invention relates to pyrrolidine derivatives of the formula (I), or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such pyrrolidine derivatives, and the use of such pyrrolidine derivatives for therapeutic purposes. The pyrrolidine derivatives are GlyT1 inhibitors.
摘要翻译： 本发明涉及式（I）的吡咯烷衍生物或其生理上耐受的盐。 本发明涉及包含这种吡咯烷衍生物的药物组合物以及这种吡咯烷衍生物用于治疗目的的用途。 吡咯烷衍生物是GlyT1抑制剂。
-
-
-
-
-
-
-
-
-
搜索结果
37 条记录 (耗时 0.043 秒)
